Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111982
Status:
COMPLETED
Last Update Posted:
2010-02-26
First Post:
2005-05-27
Brief Title:
Trial of Extended Treatment With Liatermin r-metHuGDNF Administered by Continuous Intraputaminal IPuInfusion to Subjects With Idiopathic Parkinsons Disease Who Have Completed a Previous Trial of Liatermin
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20030160
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Global Development Leader
Old Organization:
Amgen Inc
Collaborators
| Name | Class |
|---|---|
| Medtronic | INDUSTRY |